Burscheid, Germany

Karl H B/u/ Chel

This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1984-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl H B/u/ Chel. Retrieved from https://idiyas.com/inventor/karl-h-bu-chel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1984-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Karl H. Buechel from Burscheid, Germany

Introduction:

Inventor Karl H. Buechel, based in Burscheid, Germany, has made remarkable contributions to the field of pharmaceuticals with a total of 2 patents to his name.

Latest Patents:

1. Antiviral Agents: Karl's innovative work involves hydroxyethylazolyl derivatives, crucial for treating viral infections.

2. Antimicrobial Agents and Their Use: He has also developed pharmaceutical compositions with active antimicrobial compounds for combatting mycoses.

Career Highlights:

Karl H. Buechel is affiliated with Bayer Aktiengesellschaft, a renowned pharmaceutical company known for groundbreaking research and development in the healthcare industry. His tenure at Bayer has been marked by significant achievements in the realm of antiviral and antimicrobial solutions.

Collaborations:

During his tenure at Bayer Aktiengesellschaft, Karl has closely collaborated with esteemed professionals in the field, including colleagues Manfred Plempel and Hans-Ludwig Elbe. Together, they have worked on innovative projects aimed at combating infectious diseases effectively.

Conclusion:

In conclusion, Karl H. Buechel's dedication to advancing pharmaceutical research and his notable patents in antiviral and antimicrobial agents underscore his valuable contributions to the healthcare sector. His collaborations and career at Bayer Aktiengesellschaft highlight his commitment to innovation and making a positive impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…